HIV Integrase Strand Transfer Inhibitors Market: Revolutionizing HIV Treatment Strategies up to 2033
The HIV Integrase Strand Transfer Inhibitors (INSTIs) Market focuses on a class of antiretroviral drugs used to treat Human Immunodeficiency Virus (HIV) infections. INSTIs work by blocking the integrase enzyme, which HIV uses to insert its viral DNA into the host cell’s genome. By inhibiting this process, these drugs prevent the replication of the virus and slow down the progression of the disease. INSTIs are an integral part of combination antiretroviral therapy (ART) regimens, which are prescribed to manage and control HIV.